Latest Breaking News On - Eyepoint pharmaceuticals inc - Page 1 : comparemela.com

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […]

Robertw bairdDavidr guyerSecurities exchange commissionQuarter for eyepoint pharmaceuticalsInvestment advisersDeutsche bankEyepoint pharmaceuticals company profileChina universal asset management coEyepoint pharmaceuticalsEyepoint pharmaceuticals incMirae asset global investments coNews ratings for eyepoint pharmaceuticals dailyMonashee investment managementEyepoint pharmaceuticals stock performanceToth financial advisory corpInsider activity at eyepoint pharmaceuticals